GC Medical Science Corporation (KOSDAQ:142280)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Green Cross MS Co., Ltd.	109.12B	104.60B	94.07B	110.82B	100.83B
Green Cross Medis Co., Ltd.	15.83B	13.16B	11.76B	14.88B	12.79B
Consolidated Adjustments	-16.54B	-13.91B	-11.81B	-12.60B	-11.94B
Total	108.41B	103.85B	94.01B	113.11B	101.67B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
South Korea	99.67B	96.05B	87.99B	101.11B	85.11B
Overseas	8.74B	7.80B	6.02B	12.00B	16.56B
Total	108.41B	103.85B	94.01B	113.11B	101.67B

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error